University of Texas researchers identify antibody SC27 capable of neutralizing all known COVID-19 variants.

Researchers at The University of Texas, Austin, have identified an antibody named SC27 capable of neutralizing all known COVID-19 variants and related coronaviruses. Isolated from plasma of patients with breakthrough infections, SC27 shows promise for broader protection. The study highlights that hybrid immunity—stemming from both infection and vaccination—offers superior defense against COVID-19, informing future vaccine development.

September 09, 2024
13 Articles

Further Reading